BioTherapeutic's products, facilities and operations are indicative of our global reach and are subject to regulation by the U.S. Food and Drug Administration (FDA) and other regulatory authorities worldwide. Baxter works with such authorities to develop and manufacture high quality and effective products for our customers. Therapeutic options are available globally.
Ready-to-use 10% sterile, liquid preparation
Read More [+]
Sterile, stable, lyophilized preparation of purified alpha 1-proteinase inhibitor
Read More [+]
A comprehensive portfolio of Ig products for all treatment settings - hospital, outpatient, clinic, and home.
Please consult your local approved product labeling for prescribing information. Please note that not all products are licensed in all countries.